| [1] | B. Gurbuz, N. Guldiken, P. Reuken, L. Fu, K. Remih, C. Preisinger, R. Brůha, M. Leníček, J. Petrtýl, J. Reißing, M. Aly, M. Fromme, B. Zhou, I. Karkossa, K. Schubert, M. von Bergen, A. Stallmach, T. Bruns, P. Strnad,
"Biomarkers of hepatocellular synthesis in patients with decompensated cirrhosis", Hepatology international, vol. 17, no. 3, 2023, pp. 698–708.
|
| [2] | S. R. Atkinson, M. Aly, K. Remih, L. D. Tyson, N. Guldiken, R. Goldin, A. Quaglia, M. Thursz, P. Strnad,
"Serum keratin 19 (CYFRA21-1) is a prognostic biomarker in severe alcoholic hepatitis", Liver international, vol. 42, no. 5, 2022, pp. 1049–1057.
|
| [3] | D. Heinrichs, E. F. Brandt, P. Fischer, J. Köhncke, T. Wirtz, N. Guldiken, S. Djudjaj, P. Boor, D. C. Kroy, R. Weiskirchen, R. Bucala, H. E. Wasmuth, P. Strnad, C. Trautwein, J. Bernhagen, M. Berres,
"Unexpected Pro-Fibrotic Effect of MIF in Non-Alcoholic Steatohepatitis Is Linked to a Shift in NKT Cell Populations", Cells, vol. 10, no. 2, 2021, pp. 252.
|
| [4] | N. Guldiken, J. Argemi, B. Gurbuz, S. R. Atkinson, M. Oliverius, P. Fila, K. Hamesch, T. Bruns, J. Cabezas, J. J. Lozano, J. Mann, S. Cao, P. Mathurin, V. H. Shah, C. Trautwein, M. R. Thursz, R. Bataller, P. Strnad,
"Serum transferrin as a biomarker of hepatocyte nuclear factor 4 alpha activity and hepatocyte function in liver diseases", BMC medicine, vol. 19, 2021, pp. 39.
|
| [5] | T. Puengel, S. De Vos, J. Hundertmark, M. Kohlhepp, N. Guldiken, P. Pujuguet, M. Auberval, F. Marsais, K. F. Shoji, L. Saniere, C. Trautwein, T. Lüdde, P. Strnad, R. Brys, P. Clément-Lacroix, F. Tacke,
"The Medium-Chain Fatty Acid Receptor GPR84 Mediates Myeloid Cell Infiltration Promoting Steatohepatitis and Fibrosis", Journal of Clinical Medicine, vol. 9, no. 4, 2020, pp. 1140.
|